Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lauded By Industry, Loathed By FDA? New HHS ‘Good Guidance’ Rule Likely Ruffling Feathers

Dec 22 2020

• By Shawn M. Schmitt

Compliance

Related Content

'Major' Pain For FDA: Under OMB Directive, Congress Will Vote On So-Called 'Major' Rules, Guidance Docs

Apr 12 2019

Most Regs Would Get 10-Year Reviews Under HHS Proposal

Nov 05 2020

Additional Topics

International United States Regulation Guidance Documents FDA Dietary Supplements Compliance Enforcement Cosmetics Manufacturing OTC Drugs Policy Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window